Loeillot Olivier 4
4 · REPLIGEN CORP · Filed Mar 4, 2025
Insider Transaction Report
Form 4
REPLIGEN CORPRGEN
Loeillot Olivier
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2025-03-03+14,480→ 46,693 total - Award
Stock Option (Right to Buy)
2025-03-03+13,627→ 13,627 totalExercise: $155.38Exp: 2035-03-03→ Common Stock (13,627 underlying)
Footnotes (2)
- [F1]Mr. Loeillot was awarded 14,480 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- [F2]One third of the stock options will vest and become exercisable annually on March 3, 2026, March 3, 2027, and March 3, 2028.